Home PoliticsTop GOP West Virginia Lawmaker Says Trump’s Marijuana Rescheduling Order Could Bolster Push For State Legalization

Top GOP West Virginia Lawmaker Says Trump’s Marijuana Rescheduling Order Could Bolster Push For State Legalization

January 28, 2026

West Virginia marijuana legalization just got a jolt from an unlikely place: a top Republican in Charleston saying Trump’s marijuana rescheduling order could finally give lawmakers the political cover to move. Think of it like a neon sign flickering on at last call—ugly light, sure, but it changes the mood. House Speaker Roger Hanshaw is signaling that adult-use bills aren’t just blue-sky daydreams from the minority anymore. He says there are Republicans filing versions that mirror Democratic proposals. That’s no small tremor. When a GOP leader hints at bipartisan room to maneuver on cannabis policy reform, people start counting votes instead of just clocks. The headline is simple: Schedule I to Schedule III, courtesy of a presidential directive, may grease the wheels. The subtext is uglier and more honest: a lot of legislators needed cover to say out loud what their constituents have been thinking for years.

From symbolism to committee rooms

Here’s the map. Delegate Evan Hansen’s plan to regulate adult-use cannabis sits in the House Judiciary Committee, waiting for air. Across the hall, Senate Minority Leader Mike Woelfel is carrying a bill to decriminalize up to 15 grams—shifting low-level possession from a misdemeanor to a civil infraction, no jail attached. The Senate Health and Human Resources Committee chair, Brian Helton, says he’ll hear out the idea, a careful promise that still feels like movement in a state where inertia has been the default. He told his local paper he’s reviewing everything as a new chair, including the decrim bill, a polite way of saying the door isn’t bolted shut. The session ends March 14. That deadline focuses minds. Trump’s executive order instructing Attorney General Pam Bondi to expedite the move to Schedule III adds fresh heat, even if rescheduling doesn’t legalize anything by itself. What it does do, in the real world of politics, is shift the symbolism. For some members, symbolism is enough to walk from no to maybe.

West Virginia’s medical cannabis market has been an uneasy truce. Patients gripe about high prices, and too many head west or north to neighboring adult-use dispensaries for relief. Meanwhile the state sits on medical marijuana tax and fee revenue, money it hasn’t fully deployed. The treasurer’s office has worried about banking risk under federal prohibition, and that’s the kind of bureaucratic choke point that turns public policy into a waiting room. Schedule III could unjam parts of that machine—make research easier, open doors for more conventional financial services, and soften the chill around compliance. And if lawmakers actually greenlight adult-use, they’ll be talking cannabis taxation, not just enforcement. Other states have done this math: legal cannabis revenue can pay for treatment beds, roads, even the unglamorous parts of government that keep the lights on. A state-commissioned study in the islands found big sales potential and complicated tourism ripple effects, which is a reminder that legalization is policy, not magic: see Legalizing Marijuana In Hawaii Could Drive $90 Million In Monthly Sales—With Mixed Tourism Impacts—Report Commissioned By State Finds. Back home, one departing legislative leader even argued legalization could blunt the fentanyl crisis by shrinking the illicit market’s oxygen. That’s not a silver bullet, but it’s not wishful thinking either.

The new GOP calculus—and the federal crosswind

Inside the GOP, this isn’t a straight line. You can hear hawks circling in Arizona, where one Republican congressman is backing an effort to roll back legalization—even while admitting that the power of a presidential rescheduling push could reset the board: GOP Congressman Backs Effort To Roll Back Marijuana Legalization In Arizona—But Says Trump Holds ‘Power’ With Rescheduling Push. That’s the paradox: the same national messenger that comforts moderates can energize prohibitionists. And then there’s hemp, the quiet cousin that keeps getting dragged into the family fight. USDA paperwork tweaks sound boring—until you realize the industry is bracing for a federal THC clampdown that could redraw farming, testing, and supply chains: USDA Seeks White House Approval For Changes To Hemp Farming Forms As Industry Braces For Federal THC Ban. Policy turbulence in one corner of the plant ripples through the rest. And if you want a warning about what happens when regulators get too much discretion without guardrails, look to the Cornhusker State, where patients worry their protections could be yanked in the name of order: Nebraska Bill Would Let Medical Marijuana Regulators Remove Patient Protections, Advocates Say. West Virginia’s choices won’t live in a vacuum; they’ll ride the same national jet stream everyone else is flying.

So what now? If Hanshaw’s nod turns into floor time, if House Judiciary moves, if the Senate chair keeps the door open, then West Virginia could pivot from edge-of-the-map to on-the-board fast. Rescheduling to Schedule III won’t legalize adult-use or wipe out arrests on its own. But it could loosen banking, chill the fear factor around compliance, and pull the stigma out of pragmatic legislation. Decriminalization up to 15 grams would be an immediate, measurable relief—fewer lives upended for a small baggy. Full adult-use would require setting the tax rate, writing the rules, and figuring out how to spend the money without leaving it to die in an escrow purgatory. This is a coal-country kind of policy problem: grim, practical, consequence-heavy. And it’s past time to treat it that way. If you’re ready to explore compliant, high-quality options while the policy dust settles, step into our world here: https://thcaorder.com/shop/.

Leave a Reply

Whitelogothca

Subscribe

Get Weekly Discounts & 15% Off Your 1st Order.

    FDA disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.


    Please Note: Due to current state laws, we are unable to ship THCa products to the following states: Arkansas, Idaho, Minnesota, Oregon, Rhode Island.

    Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
    • Image
    • SKU
    • Rating
    • Price
    • Stock
    • Availability
    • Add to cart
    • Description
    • Content
    • Weight
    • Dimensions
    • Additional information
    Click outside to hide the comparison bar
    Compare
    Home
    Order Flower
    Account